Actxa Featured in The Business Times for Its Approach to IP and Health Technology
Actxa was recently featured in The Business Times in an article exploring how businesses can build stronger competitive advantages through intellectual property (IP) in an AI-driven economy.
The feature brings together perspectives from Tan Kong Hwee, Chief Executive of the Intellectual Property Office of Singapore (IPOS), and Dr. Du Yao, Chief Scientist at Actxa, highlighting how a strategic approach to IP can help protect innovation, support growth and create value that is difficult to replicate.
Why IP Matters in Health Technology
As AI makes innovation faster and easier to replicate, Tan Kong Hwee highlighted the growing importance of protecting the technology, data, processes and knowledge that give companies their competitive advantage.
For health technology companies like Actxa, this goes beyond the physical wearable. Whether it is a smart ring for health tracking or sleep tracking, much of the value comes from the science and algorithms working behind the scenes to turn physiological signals into meaningful health insights.
As Dr. Du Yao shared with The Business Times, Actxa built IP discipline directly into its R&D process from an early stage, protecting not only its brands but also its proprietary algorithms, methods and data.
More Than a Smart Ring Health Tracker
Growing interest in wearables as health tracker reflects a broader shift towards understanding health more proactively.
Actxa's Core Smart Ring brings together sleep, activity and cardiovascular health insights within a screenless wearable, with no subscription required.
It also introduces AI Glucose Scan, powered by Actxa's proprietary BGEM® technology, extending wearable health tracking into everyday and non-invasive glucose awareness without finger pricks or test strips.
Behind these experiences are years of research, proprietary algorithms and clinical data that form part of Actxa's wider intellectual property foundation.
Protecting the Science Behind Actxa's BGEM®
The Business Times feature highlights BGEM® as an example of how Actxa's competitive advantage extends beyond conventional patents and trademarks.
This includes Actxa's BGEM® algorithms, proprietary database of digital biomarkers, clinical datasets and accumulated scientific know-how. Dr. Du Yao explained that this combination of proprietary clinical data, digital biomarkers and scientific expertise is what makes BGEM® difficult to reproduce. It also demonstrates why protecting intangible assets is increasingly important as technologies such as AI become more capable.
As Tan Kong Hwee noted, these less-visible assets can be what truly differentiate one company from another and provide a foundation for partnerships, investment and international growth.
Building What's Next in Preventive Health
As Actxa continues to develop new health technologies and expand into new markets, a strong IP foundation helps us protect what we have built while giving our teams room to continue innovating.
Being featured in The Business Times reflects an important part of this journey: combining strong science, proprietary technology and meaningful health insights to build technology designed for the future of preventive health.
Read the full article on The Business Time here.
